SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 134 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,127,000 | -14.0% | 279,225 | -15.6% | 0.00% | 0.0% |
| Q2 2017 | $3,637,000 | +63.4% | 330,655 | +45.6% | 0.00% | 0.0% |
| Q1 2017 | $2,226,000 | -40.3% | 227,121 | -34.2% | 0.00% | 0.0% |
| Q4 2016 | $3,727,000 | +12.6% | 345,114 | +6.9% | 0.00% | 0.0% |
| Q3 2016 | $3,309,000 | -14.6% | 322,742 | +8.7% | 0.00% | 0.0% |
| Q2 2016 | $3,876,000 | -11.9% | 296,789 | -25.8% | 0.00% | 0.0% |
| Q1 2016 | $4,399,000 | +71.4% | 399,921 | +43.3% | 0.00% | 0.0% |
| Q4 2015 | $2,567,000 | +94.3% | 279,005 | +46.6% | 0.00% | – |
| Q3 2015 | $1,321,000 | -30.6% | 190,358 | -1.7% | 0.00% | -100.0% |
| Q2 2015 | $1,903,000 | +23.2% | 193,722 | +11.1% | 0.00% | – |
| Q1 2015 | $1,545,000 | -0.1% | 174,351 | -1.2% | 0.00% | – |
| Q4 2014 | $1,546,000 | +171.7% | 176,459 | +113.6% | 0.00% | – |
| Q3 2014 | $569,000 | +47.8% | 82,628 | +12.7% | 0.00% | – |
| Q2 2014 | $385,000 | +16.3% | 73,311 | +0.6% | 0.00% | – |
| Q1 2014 | $331,000 | -22.1% | 72,847 | -13.6% | 0.00% | – |
| Q4 2013 | $425,000 | +14.2% | 84,266 | +14.6% | 0.00% | – |
| Q3 2013 | $372,000 | -16.0% | 73,520 | -17.8% | 0.00% | – |
| Q2 2013 | $443,000 | -6.9% | 89,475 | -19.0% | 0.00% | – |
| Q4 2012 | $476,000 | -26.2% | 110,501 | -4.9% | 0.00% | – |
| Q3 2012 | $645,000 | -56.9% | 116,135 | -45.6% | 0.00% | -100.0% |
| Q2 2012 | $1,496,000 | +36.1% | 213,387 | +22.6% | 0.00% | 0.0% |
| Q1 2012 | $1,099,000 | – | 174,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|